On Friday, December 23, 2022, the US Departments of Labor, Treasury, and Health and Human Services jointly issued FAQ guidance (Affordable Care Act and Consolidated Appropriations Act, 2021 Implementation Part 56) offering relief to health issuers, health plans, Third-Party Administrators (TPAs) and Pharmacy Benefit Managers (PBMs) that are struggling to complete Prescription Drug Data Collection (RxDC) reporting by the December 27, 2022, deadline. The new guidance provides several pieces of relief.